Shl Telemedicine Ltd. · SIX:SHLTN
Shl Telemedicine — H1 2021 Earnings Presentation
23 slides from Shl Telemedicine's earnings presentation, Oct 1, 2021
Slide 1: SHL Telemedicine Half Year Results 2021 Presentation
SHL Telemedicine Half Year Results 2021 Presentation
Slide 2: Forward looking statements
Forward looking statements This presentation contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or ac
Slide 3: SHL Telemedicine - significantly reduces mortality, improves quality of life, and reduces healthcare costs
SHL Telemedicine - significantly reduces mortality, improves quality of life, and reduces healthcare costs • Develops technologies, solutions, and advanced telemedicine services, for diagnosis and monitoring of the heart and various chronic diseases • A leading telemedicine provider in Israel and Ge
Slide 4: SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services
SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services Use of A.I. Technology (Artificial-Intelligence) Use of large databases (Big-Data) Collaboration with leading strategic healthcare industry partners Realization of growth potential in exis
Slide 5: 2021 Summary overview - Significant progress in achieving business goals in all territories
2021 Summary overview - Significant progress in achieving business goals in all territories Israel Germany USA • Profitability with stable and significant • January 2021 – commencing Virtual • Commencement of process with FDA cash flow in Israel Visits service with BARMER for OTC clearance for Smart
Slide 6: Israel – double the annual revenues in 2022 to USD 43 – 46 million
Israel – double the annual revenues in 2022 to USD 43 – 46 million and EBITDA of USD 14 – 15.5 million B2C model - sale of cardiac monitoring services to consumers: personal 12 Lead ECG devices for transmission of remote medical data, 24/7 telemedicine center, electronic personal medical record, Mob
Slide 7: Germany – Step-up in scope of activity
Germany – Step-up in scope of activity • SHL is the market leader in Germany operating a B2B model - monitors and stabilizes chronic patients and saves costs for the Sick Funds • The Company has agreements with leading Sick Funds covering about 25% of the German health insurance market (about 20 mil
Slide 8: USA – Expanding Strategic collaborations and establishing additional strategic channels
USA – Expanding Strategic collaborations and establishing additional strategic channels The goal: not to send the patient to the ECG, but send the ECG to the patient – remote cardiac monitoring, using SmartHeart • Collaboration with Mayo Clinic, a US tier 1 medical institution, to provide patients w
Slide 9: USA – Significant progress with strategic partners
USA – Significant progress with strategic partners Collaboration with leading healthcare industry partners ✓ Commercial agreement to expand use of SmartHeart across different platforms at MAYO CLINIC Hospitals, Home Health, Nursing Homes ✓ Over 6,000 hospitals and 11,300 Home Health Agencies in the
Slide 10: Pro-Forma of Consolidating the Mediton Group results – Half Year 2021
Pro-Forma* of Consolidating the Mediton Group results – Half Year 2021 in USD million Proforma HY2021** SHL HY2020 CC** Revenues 32.0 21.1 Revenues by territories · Germany 9.2 8.8 · Israel 22.7 11.8 · Other 0.1 0.5 EBIT 3.1 0.4 Net income (loss)*** (8.3) 0.04 Share of minority**** 0.9 Adjusted EBIT
Slide 11: Financials – P&L
Financials – P&L in USD million HY2021 HY2020 CC* FY2020 CC* (except per share amounts) Revenues for the period 21.0 21.1 42.3 Performance-based revenues - - 0.1 Revenues 21.0 21.1 42.4 Revenues by territories · Germany 9.2 8.8 18.1 · Israel 11.7 11.8 23.7 · Other 0.1 0.5 0.6 EBIT (0.1) 0.4 0.4 Net
Slide 12: Financials - Balance Sheet and Cash Flow
Financials - Balance Sheet and Cash Flow in USD million HY2021 HY2020 FY2020 (except per share amounts) Cash and cash equivalents 23.6 5.0 4.1 Short term investments 17.9 3.9 6.5 Total cash and ST 41.5 8.9 10.6 investments* Short term debt - 2.2** 2.3** Current maturities - - - Long term debt - - -
Slide 13: Value Creating Events
Value Creating Events • Additional agreements with strategic partners in the US • Expansion of Doctor’s Virtual Visits activity in Germany • Additional agreements from existing strategic shannels in the US • Additional agreements for monitoring patients in Germany
Slide 14: Thank you
Thank you
Slide 15: Backup
Backup
Slide 16: SmartHeart Unique Advanced Technology
SmartHeart Unique Advanced Technology Cloud-based patented technology The only solution to perform a full 12 Lead personal ECG without assistance from a medical professional from anywhere in the world at any time within 30 seconds FDA cleared as hospital grade ECG (Golden Standard - 12 Lead) Thousan
Slide 17: Germany – legislation supports Telemedicine services
Germany – legislation supports Telemedicine services • Insured population of about 82 million by about 70 Sick Funds (Healthcare Insurances) • The four largest Sick Funds each serve about 5 to 10 million insured lives • The German healthcare services market amounts to about $ 110 billion per year •
Slide 18: USA – Shift to telemedicine services is “here to stay”
USA – Shift to telemedicine services is “here to stay” • In recent years, especially in 2020, a significant increase in telemedicine services, especially of Doctor’s Virtual Visits and leading Fortune 500 companies (Amazon, Philips) have entered this field • Regulatory change - COVID-19 driven inter
Slide 19: USA – Potential annual revenues of between $250 million to $1 billion within 5-10 years
USA – Potential annual revenues of between $250 million to $1 billion within 5-10 years Simulation of the development in annual revenues from sale of devices and services at an average of $ 40 per SmartHeart / user per month, within 5-10 years $1,250 2.50 2.25 Revenue from SmartHeart sales and cardi
Slide 20: Why now? Telemedicine services became standard and are “here to stay”
Why now? Telemedicine services became standard and are “here to stay” • The outbreak of COVID-19 illustrates the importance and the many benefits of telemedicine and the need to implement technological solutions comprehensively and to track, diagnose, offer treatment and provide ongoing care for pat
Slide 21: Key Opinion Leaders in the medical field
Key Opinion Leaders in the medical field Claus Prof. Dr. Prof. Prof. Moldenhauer Ofer Amir Helmut Platzer Wolfgang-Michael Amir Lerman Franz Former CEO of DAK, MD Former CEO MD one of the largest Head of the Cardiology AOK Bayern Sick Fund SHL Germany MAYO CLINIC German Sick Funds Department Hadassa
Slide 22: Key Leaders – SHL USA
Key Leaders – SHL USA Dr. Jonathan Fialkow Dr. Ricardo Martinez Robert Brooks Andrei Soran Chief of Cardiology, Emory University Senior Advisor for Board Member of Baptist Hospital of School of Medicine; Strategy; until recently SHL USA CEO of a health system Miami; Previously held roles at a Senior
Slide 23: Senior Management
Senior Management Yossi Vadnagra Linus Drop Erez Nachtomy Yariv Alroy CFO Managing Director CEO Chairman of the Board SHL Germany